Radiation recall with anticancer agents

Oncologist

Volumn 15, Issue 11, 2010, Pages 1227-1237

  Burris, Howard A ^a   Hurtig, Jane ^a  

^a SARAH CANNON RESEARCH INSTITUTE   (United States)

Author keywords

Antineoplastic agents; Chemotherapy; Radiation recall; Radiation recall dermatitis

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; BEVACIZUMAB; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EDATREXATE; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; HYDROXYUREA; IDARUBICIN; IXABEPILONE; LAPATINIB; NAVELBINE; PACLITAXEL; PEMETREXED; TRASTUZUMAB; UNINDEXED DRUG; VINFLUNINE;

ABDOMINAL PAIN; ADENOCARCINOMA; ARTICLE; AWARENESS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; DERMATITIS; DISEASE CLASSIFICATION; DNA DAMAGE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DUODENITIS; EAR SWELLING; ENTERITIS; EPIGLOTTIC ULCERATION; ERYTHEMA; FATIGUE; GASTRITIS; HAND FOOT SYNDROME; HUMAN; INCIDENCE; INFLAMMATION; INTESTINE OBSTRUCTION; LARYNX DISORDER; LEUKOPENIA; LIPODERMATOSCLEROSIS; LIVER BIOPSY; LYMPHANGITIS; MASTECTOMY; MUCOSA INFLAMMATION; MUSCULOSKELETAL PAIN; MYOSITIS; NAUSEA; NECROSIS; ODYNOPHAGIA; OPTIC NEURITIS; PANNICULITIS; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RADIATION NECROSIS; RADIATION RECALL; RECTAL MYOSITIS; SKIN MANIFESTATION; STOMACH HEMORRHAGE; STOMATITIS; SUPRAGLOTTITIS; SWELLING; THROMBOCYTOPENIA; ULCER; UPREGULATION; VAGINA BLEEDING; VAGINAL NECROSIS; VAGINITIS; VOMITING; VULVITIS;

ANTHRACYCLINES; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; RADIODERMATITIS; RISK FACTORS; TAXOIDS;

EID: 78649921480     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-0090     Document Type: Article

References (95)

1. Azria D, Magne N, Zouhair A et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 2005;31:555-570.
2. Caloglu M, Yurut-Caloglu V, Cosar-Alas R et al. An ambiguous phenomenon of radiation and drugs: recall reactions. Onkologie 2007;30:209-214.
3. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001;59:237-245.
4. Yeo W, Johnson PJ. Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management. Am J Clin Dermatol 2000;1:113-116.
5. DAngio GJ, Farber S, Maddock CL. Potentiation of x-ray effects by acti-nomycin D. Radiology 1959;73:175-177.
6. Kodym E, Kalinska R, Ehringfeld C et al. Frequency of radiation recall dermatitis in adult cancer patients. Onkologie 2005;28:18-21.
7. Haffty BG, Vicini FA, Beitsch P, et al. Timing ofChemotherapy after Mam-moSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys 2008;72:1441-1448.
8. Saif MW, Black G, Johnson M et al. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. Cancer Che-mother Pharmacol 2006;58:771-775.
9. Mizumoto M, Harada H, Asakura H et al. Frequency and characteristics of docetaxel-induced radiation recall phenomenon. Int J Radiat Oncol Biol Phys 2006;66:1187-1191.
10. Kitani H, Kosaka T, Fujihara T et al. The recall effect in radiotherapy: is subeffective, reparable damage involved? Int J Radiat Oncol Biol Phys 1990;18:689-695.
11. Smith KJ, Germain M, Skelton H. Histopathologic features seen with radiation recall or enhancement eruptions. J Cutan Med Surg 2002;6:535-540.
12. Ortmann E, Hohenberg G. Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine. J Clin Oncol 2002;20: 3029-3030.
13. Bronner AK, Hood AF. Cutaneous complications of chemotherapeutic agents. J Am Acad Dermatol 1983;9:645-663.
14. Burdon J, Bell R, Sullivan J et al. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA 1978;239:931.
15. Barlési F, Tummino C, Tasei AM et al. Unsuccessful rechallenge with pem-etrexed after a previous radiation recall dermatitis. Lung Cancer 2006;54: 423-425.
16. Friedlander PA, Bansal R, Schwartz L et al. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004;100: 1793-1799.
17. Donaldson SS, Glick JM, Wilbur JR. Letter: Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med 1974;81:407-408.
18. Bokemeyer C, Lampe C, Heneka M et al. Paclitaxel-induced radiation recall dermatitis. Ann Oncol 1996;7:755-756.
19. Rosen G, Tefft M, Martinez A et al. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma. Cancer 1975;35:622-630.
20. Hureaux J, le Guen Y, Tuchais C et al. Radiation recall dermatitis with pemetrexed. Lung Cancer 2005;50:255-258.
21. Miya T, Ono Y, Tanaka H et al. [Radiation recall pneumonitis induced by Gefitinib (Iressa): a case report]. Nihon Kokyuki Gakkai Zasshi 2003;41: 565-568.
22. Saif MW, Ramos J, Knisely J. Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer. JOP 2008;9:744-747.
23. Jain S, Agarwal J, Laskar S et al. Radiation recall dermatitis with gatifloxa-cin: a review of literature. J Med Imaging Radiat Oncol 2008;52:191-193.
24. Ayoola A, Lee YJ. Radiation recall dermatitis with cefotetan: a case study. The Oncologist 2006;11:1118-1120.
25. Garza LA, Yoo EK, Junkins-Hopkins JM, et al. Photo recall effect in association with cefazolin. Cutis 2004;73:79-80.
26. Jolivet J, Landry L, Pinard MF et al. A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections. Cancer Chemother Pharmacol 1987;20:169- 172.
27. Weiss RB, James WD, Major WB et al. Skin reactions induced by trime-trexate, an analog of methotrexate. Invest New Drugs 1986;4:159-163.
28. Cho S, Breedlove JJ, Gunning ST. Radiation recall reaction induced by levofloxacin. J Drugs Dermatol 2008;7:64-67.
29. Ng AW, Wong FC, Tung SY et al. Nimesulide-a new trigger of radiation recall reaction. Clin Oncol (R Coll Radiol) 2007;19:364-365.
30. Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol) 1995;7:325-326.
31. Extermann M, Vogt N, Forni M et al. Radiation recall in a patient with breast cancer treated for tuberculosis. Eur J Clin Pharmacol 1995;48:77-78.
32. Ash RB, Videtic GM. Radiation recall dermatitis after the use of the an-orexiant phentermine in a patient with breast cancer. Breast J 2006;12:186-187.
33. Putnik K, Stadler P, Schafer C et al. Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy- case report and review of literature. Radiat Oncol 2006;1:32.
34. Yeo W, Leung SF, Johnson PJ. Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. Eur J Cancer 1997;33:698-699.
35. Stelzer KJ, Griffin TW, Koh WJ. Radiation recall skin toxicity with bleo-mycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 1993;71:1322-1325.
36. Borgia F, Guarneri C, Guarneri F et al. Radiation recall dermatitis after do- cetaxel administration: absolute indication to replace the drug? Br J Der-matol 2005;153:674-675.
37. Hird AE, Wilson J, Symons S et al. Radiation recall dermatitis: case report and review of the literature. Curr Oncol 2008;15:53-62.
38. George J, Saif MW, Truss C. Radiation recall phenomenon, manifested as diffuse gastritis and upper gastrointestinal bleed after capecitabine administration. J Appl Res 2004;4:495-498.
39. Borroni G, Vassallo C, Brazzelli V et al. Radiation recall dermatitis, pan-niculitis, and myositis following cyclophosphamide therapy: histopatho-logic findings of a patient affected by multiple myeloma. Am J Dermatopathol 2004;26:213-216.
40. Wallenborn PA, Postma DS. Radiation recall supraglottitis. A hazard in head and neck chemotherapy. Arch Otolaryngol 1984;110:614-617.
41. Kennedy RD, McAleer JJ. Radiation recall dermatitis in a patient treated with dacarbazine. Clin Oncol (R Coll Radiol) 2001;13:470-472.
42. D'Angio GJ. Clinical and biologic studies of actinomycin D and roentgen irradiation. Am J Roentgenol Radium Ther Nucl Med 1962;87:106-109.
43. Stein RS. Radiation-recall enteritis after actinomycin-D and adriamycin therapy. South Med J 1978;71:960-961.
44. Tan CT, Dargeon HW, Burchenal JH. The effect of actinomycin D on cancer in childhood. Pediatrics 1959;24:544-561.
45. Wiatrak BJ, Myer CM III. Radiation recall supraglottitis in a child. Am J Otolaryngol 1991;12:227-229.
46. Camidge DR, Kunkler IH. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol (R Coll Radiol) 2000;12:272-273.
47. Culp LR, Pou AM, Jones DV et al. A case of radiation recall mucositis associated with docetaxel. Head Neck 2004;26:197-200.
48. Kandemir EG, Karabudak O, Maydagli A. Docetaxel-induced radiation recall dermatitis. Swiss Med Wkly 2005;135:34-35.
49. Morkas M, Fleming D, Hahl M. Challenges in oncology. Case 2. Radiation recall associated with docetaxel. J Clin Oncol 2002;20:867-869.
50. Piroth MD, Krempien R, Wannenmacher M et al. Radiation recall dermatitis from docetaxel. Onkologie 2002;25:438-440.
51. Zulian GB, Aapro MS. Docetaxel and radiation-recall severe mucositis. Ann Oncol 1994;5:964.
52. Cassady JR, Richter MP, Piro AJ et al. Radiation-adriamycin interactions: preliminary clinical observations. Cancer 1975;36:946-949.
53. Eifel PJ, McClure S. Severe chemotherapy-induced recall of radiation mu-cositis in a patient with non-Hodgkińs lymphoma of Waldeyers ring. Int J Radiat Oncol Biol Phys 1989;17:907-908.
54. Etcubanas E, Wilbur JR. Letter: Uncommon side effects of adriamycin (NSC-123127). Cancer Chemother Rep 1974;58:757-758.
55. Hill AB, Tattersall SF. Recall of radiation pneumonitis after intrapleural administration of doxorubicin. Med J Aust 1983;1:39-40.
56. Ma LD, Taylor GA, Wharam MD et al. Recall pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology 1993;187: 465-467.
57. Mayer EG, Poulter CA, Aristizabal SA. Complications of irradiation related to apparent drug potentiation by adriamycin. Int J Radiat Oncol Biol Phys 1976;1:1179-1188.
58. McInerney DP, Bullimore J. Reactivation of radiation pneumonitis by adriamycin. Br J Radiol 1977;50:224-227.
59. Jimeno A, Ciruelos EM, Castellano D et al. Radiation recall dermatitis induced by pegylated liposomal doxorubicin. Anticancer Drugs 2003;14: 575-576.
60. Perez EA, Campbell DL, Ryu JK. Radiation recall dermatitis induced by edatrexate in a patient with breast cancer. Cancer Invest 1995;13:604-607.
61. Fontana JA. Radiation recall associated with VP-16-213 therapy. Cancer Treat Rep 1979;63:224-225.
62. von Essen CF, Kligerman MM, Calabresi P. Radiation and 5-fluorouracil: A controlled clinical study. Radiology 1963;81:1018-1026.
63. Sroa N, Bartholomew DA, Magro CM. Lipodermatosclerosis as a form of vascular compromise-associated radiation recall dermatitis: case report and a review of literature. J Cutan Pathol 2006;33(suppl 2):55-59.
64. Bar-Sela G, Beny A, Bergman R et al. Gemcitabine-induced radiation recall dermatitis: case report. Tumori 2001;87:428-430.
65. Castellano D, Hitt R, Cortes-Funes H et al. Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine. J Clin Oncol 2000;18:695-696.
66. Fakih MG. Gemcitabine-induced rectus abdominus radiation recall. JOP 2006;7:306-310.
67. Fogarty G, Ball D, Rischin D. Radiation recall reaction following gemcit-abine. Lung Cancer 2001;33:299-302.
68. Ganem G, Solal-Celigny P, Joffroy A et al. Radiation myositis: the possible role of gemcitabine. Ann Oncol 2000;11:1615-1616.
69. Jeter MD, Janne PA, Brooks S et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 2002;53:394-400.
70. Marisavljevic D, Ristic B, Hajder J. Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma. Am J Hematol 2005;80:91.
71. Miura G, Matsumoto T, Tanaka N et al. [Two cases of radiation myositis probably induced by recall phenomenon]. Nippon Igaku Hoshasen Gakkai Zasshi 2003;63:420-422.
72. Saif MW, Sellers S, Russo S. Gemcitabine-related radiation recall in a patient with pancreatic cancer. Anticancer Drugs 2006;17:107-111.
73. Schwartz BM, Khuntia D, Kennedy AW et al. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecol Oncol 2003;91:421-422.
74. Tan DHS, Bunce PE, Liles WC et al. Gemcitabine-related pseudocelluli-tis: report of 2 cases and review of the literature. Clin Infect Dis 2007;45: e72-e76.
75. Welsh JS, Torre TG, DeWeese TL et al. Radiation myositis. Ann Oncol 1999;10:1105-1108.
76. Schwarte S, Wagner K, Karstens JH et al. Radiation recall pneumonitis induced by gemcitabine. Strahlenther Onkol 2007;183:215-217.
77. Castellano D, Hitt R, Ciruelos E et al. Biweekly vinorelbine and gemcitab-ine: a phase I dose-finding study in patients with advanced solid tumors. Ann Oncol 2003;14:783-787.
78. Burstein HJ. Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine. J Clin Oncol 2000;18:693-694.
79. Sears ME. Erythema in areas of previous irradiation in patients treated with hydroxyurea (NSC-32065). Cancer Chemother Rep 1964;40:31-32.
80. Gabel C, Eifel PJ, Tornos C et al. Radiation recall reaction to idarubicin resulting in vaginal necrosis. Gynecol Oncol 1995;57:266-269.
81. Thomas R, Stea B. Radiation recall dermatitis from high-dose interferon alfa-2b. J Clin Oncol 2002;20:355-357.
82. Kellie SJ, Plowman PN, Malpas JS. Radiation recall and radiosensitization with alkylating agents. Lancet 1987;1:1149-1150.
83. Kharfan Dabaja MA, Morgensztern D, Markoe AM et al. Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease. Am J Clin Oncol 2000;23:531-533.
84. Chan RT, Au GK, Ho JW et al. Radiation recall with oxaliplatin: report of a case and a review of the literature. Clin Oncol (R Coll Radiol) 2001;13: 55-57.
85. McCarty MJ, Peake MF, Lillis P et al. Paclitaxel-induced radiation recall dermatitis. Med Pediatr Oncol 1996;27:185-186.
86. Phillips KA, Urch M, Bishop JF. Radiation-recall dermatitis in a patient treated with paclitaxel. J Clin Oncol 1995;13:305.
87. Schweitzer VG, Juillard GJ, Bajada CL et al. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 1995;76:1069-1072.
88. Shenkier T, Gelmon K. Paclitaxel and radiation-recall dermatitis. J Clin Oncol 1994;12:439.
89. Kundak I, Oztop I, Soyturk M et al. Paclitaxel-carboplatin induced radiation recall colitis. Tumori 2004;90:256-258.
90. Boström A, Sjolin-Forsberg G, Wilking N et al. Radiation recall-another call with tamoxifen. Acta Oncol 1999;38:955-959.
91. Kundranda MN, Daw HA. Tamoxifen-induced radiation recall dermatitis. Am J Clin Oncol 2006;29:637-638.
92. Parry BR. Radiation recall induced by tamoxifen. Lancet 1992;340:49.
93. Singer EA, Warren RD, Pennanen MF et al. Tamoxifen-induced radiation recall dermatitis. Breast J 2004;10:170-171.
94. Lampkin BC. Skin reaction to vinblastine. Lancet 1969;1:891.
95. Nemechek PM, Corder MC. Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 1992;70:1605-1606.